In Face of Jury Verdict, Stratagene Advances Molecular Dx Plans with Reference Lab Pact | GenomeWeb

Following through on a promise to investors following a lost patent-infringement battle, Stratagene has advanced its plans to participate in the molecular diagnostics market by penning an alliance with a reference lab that will use its FullVelocity technology to develop and market diagnostic assays, the firm said this week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.